Aspen Pharmacare Holdings Ltd Asset Resilience Ratio
Aspen Pharmacare Holdings Ltd asset resilience ratio. Aspen Pharmacare Holdings Ltd (APN) has an Asset Resilience Ratio of 6.67% as of December 2022. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See defensive interval ratio of Aspen Pharmacare Holdings Ltd to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Aspen Pharmacare Holdings Ltd (2010–2022)
Asset resilience ratio of Aspen Pharmacare Holdings Ltd from 2010 to 2022. This chart shows how Aspen Pharmacare Holdings Ltd's Asset Resilience Ratio has changed over time. Read total liabilities of Aspen Pharmacare Holdings Ltd for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Aspen Pharmacare Holdings Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see APN total assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ZAC8.04 Billion | 6.67% |
| Short-term Investments | ZAC0.00 | 0% |
| Total Liquid Assets | ZAC8.04 Billion | 6.67% |
Asset Resilience Insights
- Limited Liquidity: Aspen Pharmacare Holdings Ltd maintains only 6.67% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Aspen Pharmacare Holdings Ltd Industry Peers by Asset Resilience Ratio
Compare Aspen Pharmacare Holdings Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2 |
Drug Manufacturers - Specialty & Generic | 0.20% |
|
Changchun High & New Technology Industries Group Inc
SHE:000661 |
Drug Manufacturers - Specialty & Generic | 5.50% |
|
Chengdu Kanghong Pharmaceuticals Group Co Ltd
SHE:002773 |
Drug Manufacturers - Specialty & Generic | 29.37% |
|
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267 |
Drug Manufacturers - Specialty & Generic | 0.01% |
|
Shenzhen Chipscreen Biosciences Co
SHG:688321 |
Drug Manufacturers - Specialty & Generic | 5.10% |
|
Cronos Group Inc
TO:CRON |
Drug Manufacturers - Specialty & Generic | 69.94% |
|
Jiangsu Kanion Pharmaceutical Co Ltd
SHG:600557 |
Drug Manufacturers - Specialty & Generic | 0.29% |
|
HPGC Renmintongtai Pharmaceutical Corp
SHG:600829 |
Drug Manufacturers - Specialty & Generic | 0.00% |
Aspen Pharmacare Holdings Ltd Asset Resilience Ratio by Year (2010–2022)
Aspen Pharmacare Holdings Ltd asset resilience ratio by year from 2010 to 2022. The table below shows the annual Asset Resilience Ratio data for Aspen Pharmacare Holdings Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2022-06-30 | 0.29% | ZAC318.00 Million ≈ $169.00K |
ZAC111.38 Billion ≈ $59.19 Million |
+0.28pp |
| 2021-06-30 | 0.01% | ZAC9.00 Million ≈ $4.78K |
ZAC109.68 Billion ≈ $58.29 Million |
+0.00pp |
| 2020-06-30 | 0.00% | ZAC6.00 Million ≈ $3.19K |
ZAC133.17 Billion ≈ $70.77 Million |
+0.00pp |
| 2019-06-30 | 0.00% | ZAC2.00 Million ≈ $1.06K |
ZAC122.32 Billion ≈ $65.00 Million |
+0.71pp |
| 2018-06-30 | -0.71% | ZAC-940.00 Million ≈ $-499.56K |
ZAC132.84 Billion ≈ $70.60 Million |
-9.92pp |
| 2017-06-30 | 9.21% | ZAC10.71 Billion ≈ $5.69 Million |
ZAC116.30 Billion ≈ $61.81 Million |
+9.17pp |
| 2015-06-30 | 0.03% | ZAC30.20 Million ≈ $16.05K |
ZAC88.42 Billion ≈ $46.99 Million |
+0.03pp |
| 2010-06-30 | 0.00% | ZAC100.00K ≈ $53.14 |
ZAC19.80 Billion ≈ $10.52 Million |
-- |
About Aspen Pharmacare Holdings Ltd
Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and markets specialty and branded pharmaceutical products in Africa, the Middle East, the Americas, Europe CIS, Australasia, and Asia. It operates through Commercial Pharmaceuticals and Manufacturing segments. The company offers injectables for therapeutic areas, such as anaesthetics, anticoagulants, antithrombotic ag… Read more